Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons
- PMID: 9006329
- PMCID: PMC1858540
Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons
Abstract
In Parkinson's disease and other Lewy-body-associated disorders, the substantia nigra pars compacta undergoes degeneration, but the mechanism of cell death has not been previously described. The substantia nigra of normal and Alzheimer's disease cases were compared with substantia nigra from patients with Lewy-body-associated disorders (Parkinson's disease, concomitant Alzheimer's/Parkinson's disease, and diffuse Lewy body disease) using in situ end labeling to detect fragmented DNA. In situ end-labeled neurons demonstrated changes resembling apoptosis: nuclear condensation, chromatin fragmentation, and formation of apoptotic-like bodies. Ultrastructural analysis confirmed nuclear condensation and formation of apoptotic-like bodies. Apoptotic-like changes were seen in the substantia nigra of both normal and diseased cases; concomitant Alzheimer's/Parkinson's disease and diffuse Lewy body disease cases had significantly higher amounts of apoptotic-like changes than normal controls or Alzheimer patients. The finding of neuronal death by apoptosis may have relevance for the development of new treatment strategies for Parkinson's disease and related disorders.
Similar articles
-
Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.J Comp Neurol. 1993 Mar 15;329(3):328-36. doi: 10.1002/cne.903290304. J Comp Neurol. 1993. PMID: 8459049
-
Pathological changes in dendrites of substantia nigra neurons in Parkinson's disease: a Golgi study.Histol Histopathol. 1991 Jul;6(3):373-80. Histol Histopathol. 1991. PMID: 1725760
-
Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.Neuroscience. 2006 Jun 19;140(1):67-76. doi: 10.1016/j.neuroscience.2006.02.007. Epub 2006 Mar 14. Neuroscience. 2006. PMID: 16533572
-
The neuromythology of Parkinson's Disease.Parkinsonism Relat Disord. 2004 Jul;10(5):319-22. doi: 10.1016/j.parkreldis.2004.03.006. Parkinsonism Relat Disord. 2004. PMID: 15196512 Review.
-
The relationship of Alzheimer-type pathology to dementia in Parkinson's disease.J Neural Transm Suppl. 1997;49:23-31. doi: 10.1007/978-3-7091-6844-8_3. J Neural Transm Suppl. 1997. PMID: 9266411 Review.
Cited by
-
Alpha-synuclein structures from fluorescence energy-transfer kinetics: implications for the role of the protein in Parkinson's disease.Proc Natl Acad Sci U S A. 2004 Nov 23;101(47):16466-71. doi: 10.1073/pnas.0407307101. Epub 2004 Nov 9. Proc Natl Acad Sci U S A. 2004. PMID: 15536128 Free PMC article.
-
Neuronal cell death in neurodegenerative diseases: recurring themes around protein handling.J Cell Mol Med. 2008 Dec;12(6A):2263-80. doi: 10.1111/j.1582-4934.2008.00402.x. Epub 2008 Jun 27. J Cell Mol Med. 2008. PMID: 18624755 Free PMC article. Review.
-
Atomic force microscopy based nanoassay: a new method to study α-Synuclein-dopamine bioaffinity interactions.Sci Rep. 2014 Jun 20;4:5366. doi: 10.1038/srep05366. Sci Rep. 2014. PMID: 24947141 Free PMC article.
-
Effects of Melatonin Levels on Neurotoxicity of the Medial Prefrontal Cortex in a Rat Model of Parkinson's Disease.Chin Med J (Engl). 2017 Nov 20;130(22):2726-2731. doi: 10.4103/0366-6999.218025. Chin Med J (Engl). 2017. PMID: 29133763 Free PMC article.
-
Dopaminergic neurons lacking Caspase-3 avoid apoptosis but undergo necrosis after MPTP treatment inducing a Galectin-3-dependent selective microglial phagocytic response.Cell Death Dis. 2024 Aug 27;15(8):625. doi: 10.1038/s41419-024-07014-9. Cell Death Dis. 2024. PMID: 39223107 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous